1. HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. (31st December 2018) Authors: Wang, Y; Jiang, T; Qin, Z; Jiang, J; Wang, Q; Yang, S; Rivard, C; Gao, G; Ng, T L; Tu, M M; Yu, H; Ji, H; Zhou, C; Ren, S; Zhang, J; Bunn, P; Doebele, R C; Camidge, D R; Hirsch, F R Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗